Kiechle M - Search Results

1

NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancer.

Konrad SM, Schwamborn K, Krüger A, Honert K, Schmitt M, Hellmann D, Schmalfeldt B, Meindl A, Kiechle M, Quante AS, Brambs C, Grill S, Ramser J. Konrad SM, et al. Among authors: kiechle m. Biomark Med. 2022 Oct;16(14):1029-1041. doi: 10.2217/bmm-2021-0781. Epub 2022 Nov 29. Biomark Med. 2022. PMID: 36444691

2

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

Harbeck N, Kates RE, Look MP, Meijer-Van Gelder ME, Klijn JG, Krüger A, Kiechle M, Jänicke F, Schmitt M, Foekens JA. Harbeck N, et al. Among authors: kiechle m. Cancer Res. 2002 Aug 15;62(16):4617-22. Cancer Res. 2002. PMID: 12183417

3

Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts.

Harbeck N, Schmitt M, Kates RE, Kiechle M, Zemzoum I, Jänicke F, Thomssen C. Harbeck N, et al. Among authors: kiechle m. Clin Breast Cancer. 2002 Aug;3(3):196-200. doi: 10.3816/CBC.2002.n.023. Clin Breast Cancer. 2002. PMID: 12196277 Review.

4

Detailed analysis of five mutations in dihydropyrimidine dehydrogenase detected in cancer patients with 5-fluorouracil-related side effects.

Gross E, Ullrich T, Seck K, Mueller V, de Wit M, von Schilling C, Meindl A, Schmitt M, Kiechle M. Gross E, et al. Among authors: kiechle m. Hum Mutat. 2003 Dec;22(6):498. doi: 10.1002/humu.9201. Hum Mutat. 2003. PMID: 14635116

5

[Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD].

Schmutzler R, Schlegelberger B, Meindl A, Gerber WD, Kiechle M; Hereditary Breast- and Ovarian Cancer Consortium, German Cancer AiD. Schmutzler R, et al. Among authors: kiechle m. Zentralbl Gynakol. 2003 Dec;125(12):494-506. doi: 10.1055/s-2003-44815. Zentralbl Gynakol. 2003. PMID: 14755360 German.

6

Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer.

Harbeck N, Kates RE, Gauger K, Willems A, Kiechle M, Magdolen V, Schmitt M. Harbeck N, et al. Among authors: kiechle m. Thromb Haemost. 2004 Mar;91(3):450-6. doi: 10.1160/TH03-12-0798. Thromb Haemost. 2004. PMID: 14983219 Review.

7

Limited relevance of the CHEK2 gene in hereditary breast cancer.

Dufault MR, Betz B, Wappenschmidt B, Hofmann W, Bandick K, Golla A, Pietschmann A, Nestle-Krämling C, Rhiem K, Hüttner C, von Lindern C, Dall P, Kiechle M, Untch M, Jonat W, Meindl A, Scherneck S, Niederacher D, Schmutzler RK, Arnold N. Dufault MR, et al. Among authors: kiechle m. Int J Cancer. 2004 Jun 20;110(3):320-5. doi: 10.1002/ijc.20073. Int J Cancer. 2004. PMID: 15095295 Free article.

8

Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer.

Harbeck N, Kates RE, Schmitt M, Gauger K, Kiechle M, Janicke F, Thomassen C, Look MP, Foekens JA. Harbeck N, et al. Among authors: kiechle m. Clin Breast Cancer. 2004 Dec;5(5):348-52. doi: 10.3816/cbc.2004.n.040. Clin Breast Cancer. 2004. PMID: 15585071 Review.

9

Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in a cohort of Caucasian individuals.

Seck K, Riemer S, Kates R, Ullrich T, Lutz V, Harbeck N, Schmitt M, Kiechle M, Diasio R, Gross E. Seck K, et al. Among authors: kiechle m. Clin Cancer Res. 2005 Aug 15;11(16):5886-92. doi: 10.1158/1078-0432.CCR-04-1784. Clin Cancer Res. 2005. PMID: 16115930

10

Development of a thinner and more flexible type of minihysteroscope with a controlled 90-degree bendable tip for vision-guided endometrium biopsy.

Jacobs VR, Paepke S, Schwarz-Boeger U, Fischer T, Pildner von Steinburg S, Plattner B, Schmalfeldt B, Schaaf H, Kiechle M. Jacobs VR, et al. Among authors: kiechle m. J Minim Invasive Gynecol. 2005 Sep-Oct;12(5):426-31. doi: 10.1016/j.jmig.2005.06.013. J Minim Invasive Gynecol. 2005. PMID: 16213429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page